The foundation of Leerink Partners’ success is deeply intertwined with Jeffrey Leerink’s entrepreneurial spirit and keen understanding of the healthcare landscape. His journey began with the co-founding of MEDACorp in 1996. Recognizing the critical need for informed insights into the commercial viability of biotherapeutics and medical devices, MEDACorp emerged as a pivotal resource for healthcare companies and investors alike. Today, MEDACorp continues to provide invaluable industry and market intelligence, reinforcing Leerink Partners’ strategic advantage.
Further demonstrating his commitment to innovation within healthcare, Mr. Leerink co-founded Humedica, Inc. in 2008. This clinical intelligence company harnessed the power of data to improve healthcare outcomes. Humedica’s groundbreaking approach was recognized by Optum, a subsidiary of UnitedHealth Group, which acquired the company in 2013, underscoring the value and foresight of Mr. Leerink’s ventures.
In 2013, Mr. Leerink expanded his vision by establishing Leerink Capital Partners, a multi-strategy asset management firm focused exclusively on the healthcare domain. This strategic move further solidified Leerink Partners’ comprehensive service offering within the healthcare ecosystem. In 2019, Leerink Capital Partners’ private equity funds were strategically integrated into SVB Capital, enhancing their reach and impact.
The year 2019 marked a significant chapter in Leerink Partners’ history when Mr. Leerink spearheaded the sale of the firm to Silicon Valley Bank. He subsequently assumed the role of CEO of SVB Securities, guiding the entity until 2023. Demonstrating his unwavering dedication to the independent ethos of Leerink Partners, Mr. Leerink led a successful management buyout in 2023, effectively restoring Leerink Partners to its independent status. This pivotal move reaffirmed the firm’s commitment to its specialized focus and client-centric approach within healthcare investment banking.
Beyond his professional achievements, Jeffrey Leerink is deeply committed to advancing healthcare and education through philanthropic endeavors. His dedication to the healthcare industry is evident in his numerous advisory roles and board memberships within healthcare companies, reflecting his ongoing commitment to shaping the future of the sector. Moreover, Mr. Leerink serves as the Vice Chair of the Harvard Medical School Board of Fellows, contributing to the advancement of medical education and research. His commitment extends to community engagement through his service on the Board of Big Brothers Big Sisters of Eastern Massachusetts, demonstrating a broader dedication to societal well-being.
Mr. Leerink’s academic foundation is a Bachelor of Arts degree in Economics from Union College. This background, combined with his decades of experience and visionary leadership, has been instrumental in establishing Leerink Partners as the leading independent investment bank exclusively focused on healthcare, consistently delivering exceptional value to clients and shaping the industry landscape.
